Dr Rao has an experience of more than 30 years in the field of Medical Oncology and has treated over two lakh patients across the globe.
Prior joining to Paras Hospitals, Gurugram, he has worked with many premier institutes; Max Super Specialty Hospital, BLK Super speciality hospital, Artemis Hospital, Rajiv Gandhi Cancer Institute, R& R Hospital to list a few.
His areas of speciality are lung cancer, pleura, breast, ovarian, cervical, esophagus, stomach, small intestine, colon, rectum, liver, gall bladder, pancreas, sarcomas, melanomas, lymphomas of all types, brain tumours, kidney, urinary bladder, prostrate, head and neck cancer.
His skill lies in chemotherapy, targeted therapy, hormonal therapy, immunotherapy, supportive and palliative care and precision cancer care.
Also, he is an active member of the American Society of Clinical Oncology (ASCO), European Society of Medical Oncology (ESMO), Indian Society of Medical and Pediatric Oncology (ISMPO) among others.
“We extend our warm welcome to Dr (Col) Ranga Rao to the Paras family with an emphasis on specialized cancer clinics. He is a veteran in the field of oncology and has an enviable record. The wealth of knowledge and the range of expertise he brings will be beneficial to those who come here for treatment,” said Dr Sameer Kulkarni, Facility Director, Paras Hospital, Gurugram.
Dr Rao completed his DM (Medical Oncology) from Dr Muthulaxmi College of Oncological Sciences, Cancer Institute, Adayar, Chennai. He perused MD (Internal Medicine) from Armed Forces Medical College, Pune, Maharashtra and MBBS from Jawaharlal Nehru Medical College, Ajmer.
“I am enthused by the opportunity extended by Paras Hospitals and will offer the best of my efforts. We shall be organizing cancer awareness and check up to enable prevention and early diagnosis. It is essential to spread the spirit of prevention early so that we can save numerous lives and families from the burden of disease that has gripped India in its strong clutches,” said Dr Rao.
Each Paras centre is equipped to provide cutting edge treatment with exceptional patient outcomes, with patient-centric approach using cost-effective, evidence-based cancer care including precision care.
This story is provided by PRNewswire. ANI will not be responsible in any way for the content of this article. (ANI/PRNewswire)